Just last week, we wrote about how drug development costs are keeping obesity drugs off the market. This week, we take a look at Alzheimer’s...

We’ve covered the importance of tactical vs strategic outsourcing and the potential for savings and innovation by outsourcing, and now we’ll be...

Obesity has been linked to cancer, heart disease, high blood pressure, diabetes, and stroke. As a common underlying factor in so many preventable...

In the past 10 years, we’ve experienced a shift: the move from in-person to virtual interactions. Email, Facebook, Twitter, and a slew of other...

More than 366 million people are living with diabetes, according to the International Diabetes Federation. Diabetes has associated health risks...

This is Part 2 in a four-part series in which Dr. Kevin Lustig and Dr. Maria Thompson explore a new paradigm for virtual drug discovery in a...

Innovative research is being performed in universities worldwide. There is a quest for knowledge, glory, and most importantly, helping the sick. On...

The San Diego Business Journal recently interviewed Scientist’s CEO Kevin Lustig about his latest side venture: “Bio, Tech and Beyond”, which is a...

We work with researchers from big and large pharma to discover new CROs and outsource drug discovery. Whether they have worked with a handful of...

As previously discussed, drug development costs have been rising to almost prohibitive levels. In 1975, the average approved drug cost $100 million...